Clinical Trial: Feasibility Study of Kaiser Score Combined with Apparent Diffusion Coefficient in the Diagnosis of Nonmass Enhancement Lesions of the Breast (China)

Posted On: 2026-09-10

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Feasibility Study of Kaiser Score Combined with Apparent Diffusion Coefficient in the Diagnosis of Nonmass Enhancement Lesions of the Breast'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132023

Registration Time: 2026/09/09

Type: Diagnostic test

Primary Sponsor: The Eighth People‘s Hospital of Jinan

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341689

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Feasibility Study of Kaiser Score Combined with Apparent Diffusion Coefficient in the Diagnosis of Nonmass Enhancement Lesions of the Breast (China)